SCHEMBL2183272

SCHEMBL2183272

COC(=O)c1c(-c2ccco2)csc1N

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 14/20 0.74
HSD17B10 Q99714 10/20 0.74
MEN1 O00255 6/20 0.74
KMT2A Q03164 6/20 0.74
ALOX15 P16050 2/20 0.74
TDP1 Q9NUW8 2/20 0.74
HPGD P15428 6/20 0.62
LMNA P02545 3/20 0.62
PRKCZ Q05513 3/20 0.62
MAPT P10636 10/20 0.60
MAPK1 P28482 3/20 0.60
TSHR P16473 3/20 0.60
POLB P06746 3/20 0.54
PKM P14618 2/20 0.54
GAA P10253 2/20 0.51
RECQL P46063 1/20 0.51
CFTR P13569 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
HSP90AA1 P07900 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688353 0.85 ALDH1A1 (1.00) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL688523 0.77 PRKCZ (1.00) ALDH1A1HSD17B10MEN1KMT2AHPGD
SCHEMBL5322468 0.74 MAPT (0.73) ALDH1A1HSD17B10MEN1KMT2ATDP1
SCHEMBL8198873 0.73 ALDH1A1 (0.68) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL5322173 0.73 ALDH1A1 (1.00) ALDH1A1HSD17B10MEN1KMT2AHPGD
SCHEMBL8200826 0.72 ALDH1A1 (0.50) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL8288639 0.71 ALDH1A1 (0.76) ALDH1A1HSD17B10MEN1KMT2AHPGD
SCHEMBL2182710 0.71 PRKCZ (1.00) ALDH1A1HSD17B10MEN1KMT2AALOX15
SCHEMBL3995640 0.71 ALDH1A1 (0.76) ALDH1A1HSD17B10MEN1KMT2AHPGD
SCHEMBL3932115 0.71 ALDH1A1 (0.76) ALDH1A1HSD17B10MEN1KMT2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765757-B2 3-heterocyclic substituted indole derivatives and methods of use thereof MERCK SHARP & DOHME CORP. (US) 2014-07-01 US disclosed
EP-2222660-B1 3-HETEROCYCLIC SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF MERCK SHARP & DOHME (US) 2014-03-26 EP disclosed
US-20110165118-A1 3-HETEROCYCLIC SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF SCHERING CORPORATION 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165118-A1 3-HETEROCYCLIC SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF IDO1, IDO2, HTR3C ALDH1A1 1668/4885HSD17B10 1328/4885MEN1 1468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.